Medinova Diagnostic Service Limited (MDSL) has taken a significant step towards its merger with Vijaya Diagnostic Centre Limited (VDCL), as announced in a recent corporate filing. The company has received the certified true copy of the National Company Law Tribunal (NCLT) order dated October 13, 2025, approving the amalgamation between the two diagnostic service providers.

Key Details of the Merger

Merger Process and Next Steps

The merger process is now in its final stages, with both companies required to take crucial steps to complete the amalgamation:

1. Filing with Registrar of Companies: Both MDSL and VDCL must file the certified true copy of the NCLT order along with the amalgamation scheme with the Registrar of Companies in Hyderabad.

2. Effective Date: The merger will become effective on the date when both companies complete the filing process mentioned above.

3. Public Announcement: Once the scheme becomes operational, the effective date will be communicated to the stock exchanges for public dissemination.

Implications and Outlook

This merger represents a significant development in the diagnostic services sector. The amalgamation of Medinova Diagnostic Services with Vijaya Diagnostic Centre is expected to combine the strengths and resources of both entities, potentially leading to enhanced service offerings and operational efficiencies.

Investors and stakeholders of both companies should keep a close watch on further announcements regarding the completion of the merger process and its potential impact on the companies' operations and market position.

As the diagnostic services industry continues to evolve, consolidation moves like this merger may play a crucial role in shaping the competitive landscape and service quality in the sector.

The National Company Law Tribunal (NCLT), Hyderabad Bench, has sanctioned the scheme of amalgamation between Medinova Diagnostic Service and Vijaya Diagnostic Centre Limited, marking a significant development in the diagnostic services sector.

Key Details of the Amalgamation

• Effective Date: The final order was pronounced on October 13, 2025
• Appointed Date: April 1, 2024
• Share Exchange Ratio: Shareholders of Medinova Diagnostic Service will receive 1 equity share of Vijaya for every 22 shares held

Impact on Shareholding

Vijaya Diagnostic Centre, which currently holds a 62.14% stake in Medinova Diagnostic Service, will see its shares in the transferor company cancelled as part of the amalgamation process. This move is expected to simplify the group structure and create operational synergies.

Business Operations

Both companies operate in the diagnostic services sector, offering:

• Pathological investigations
• Radiology services
• Nuclear medicine

Objectives of the Amalgamation

The merger aims to:

1. Create synergies between the businesses
2. Reduce operational costs
3. Simplify the group structure

Regulatory Considerations

The NCLT has addressed various regulatory concerns, including:

• Pending inquiries against Medinova Diagnostic Service
• MSME dues

The transferee company has provided necessary undertakings for compliance with these matters.

Stock Exchange Listings

• Medinova Diagnostic Service shares are listed on BSE
• Vijaya trades on both BSE and NSE

Conclusion

This amalgamation represents a strategic move in the diagnostic services industry, potentially leading to a stronger, more efficient entity. Stakeholders will be watching closely to see how the combined company leverages its expanded capabilities and market presence in the coming months.